Download presentation
Presentation is loading. Please wait.
Published byVerawati Wibowo Modified over 6 years ago
1
Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on plasma apolipoprotein C- III levels in patients from the MARINE and ANCHOR studies Christie M. Ballantyne, MD, Harold E. Bays, MD, Rene A. Braeckman, PhD, Sephy Philip, RPh, PharmD, William G. Stirtan, PhD, Ralph T. Doyle, BA, Paresh N. Soni, MD, PhD, Rebecca A. Juliano, PhD Journal of Clinical Lipidology Volume 10, Issue 3, Pages e1 (May 2016) DOI: /j.jacl Copyright © 2016 National Lipid Association Terms and Conditions
2
Figure 1 Median percentage change from baseline to week 12 vs placebo (Hodges–Lehmann medians) in ApoC-III plasma levels in patients from the MARINE and ANCHOR studies. ∗P < .0001; †P < .001; ‡P < .05. ApoC-III, apolipoprotein C-III; MARINE, Multi-Center, Placebo-Controlled, Randomized, Double-Blind, 12-Week Study With an Open-Label Extension. Journal of Clinical Lipidology , e1DOI: ( /j.jacl ) Copyright © 2016 National Lipid Association Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.